| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |